Contraception and pregnancy in patients with rheumatic disease

Lisa R. Sammaritano, Bonnie L. Bermas

Research output: Book/ReportBook

Abstract

Rheumatic (or systemic autoimmune) diseases disproportionately affect young women: the female-to-male ratio for patients with systemic lupus erythematosus during the reproductive years is approximately 9:1. In the mid-to late-twentieth century, women with rheumatic disease diagnoses were often advised to avoid pregnancy due to fear of disease exacerbation and adverse outcome. In more recent years, many women with rheumatic disease have deferred childbearing until a later age due to active disease or unsafe therapies. However, with advances in rheumatology therapies, obstetric monitoring, and reproductive medicine technologies, increasing numbers of women with rheumatic diseases are pursuing pregnancy. As a result, obstetricians and rheumatologists need to be aware of the current state of knowledge and the recommendations for management of pregnancy in these patients. Contraception and Pregnancy in Patients with Rheumatic Disease explains the basics of contraception, fertility treatment, and pregnancy in rheumatic disease patients and serves as a guide and reference tool for both rheumatologists and OB/GYNs. Most general rheumatologists and OB/GYNs have limited experience in caring for rheumatic disease patients during pregnancy, and many do not have ready access to expert colleagues in this area. This book summarizes the current state of knowledge and presents a general approach for assessment of the rheumatic disease patient considering pregnancy, hormonal contraception or infertility treatment.

Original languageEnglish (US)
PublisherSpringer New York
Number of pages313
ISBN (Electronic)9781493906734
ISBN (Print)1493906720, 9781493906727
DOIs
StatePublished - Mar 1 2014

Fingerprint

Rheumatic Diseases
Contraception
Pregnancy
Reproductive Techniques
Reproductive Medicine
Knowledge Management
Rheumatology
Therapeutics
Systemic Lupus Erythematosus
Infertility
Autoimmune Diseases
Obstetrics
Fear
Fertility
Disease Progression
Rheumatologists

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Contraception and pregnancy in patients with rheumatic disease. / Sammaritano, Lisa R.; Bermas, Bonnie L.

Springer New York, 2014. 313 p.

Research output: Book/ReportBook

Sammaritano, Lisa R. ; Bermas, Bonnie L. / Contraception and pregnancy in patients with rheumatic disease. Springer New York, 2014. 313 p.
@book{77076e9ff6cd42b2acbfe39ccd4215a2,
title = "Contraception and pregnancy in patients with rheumatic disease",
abstract = "Rheumatic (or systemic autoimmune) diseases disproportionately affect young women: the female-to-male ratio for patients with systemic lupus erythematosus during the reproductive years is approximately 9:1. In the mid-to late-twentieth century, women with rheumatic disease diagnoses were often advised to avoid pregnancy due to fear of disease exacerbation and adverse outcome. In more recent years, many women with rheumatic disease have deferred childbearing until a later age due to active disease or unsafe therapies. However, with advances in rheumatology therapies, obstetric monitoring, and reproductive medicine technologies, increasing numbers of women with rheumatic diseases are pursuing pregnancy. As a result, obstetricians and rheumatologists need to be aware of the current state of knowledge and the recommendations for management of pregnancy in these patients. Contraception and Pregnancy in Patients with Rheumatic Disease explains the basics of contraception, fertility treatment, and pregnancy in rheumatic disease patients and serves as a guide and reference tool for both rheumatologists and OB/GYNs. Most general rheumatologists and OB/GYNs have limited experience in caring for rheumatic disease patients during pregnancy, and many do not have ready access to expert colleagues in this area. This book summarizes the current state of knowledge and presents a general approach for assessment of the rheumatic disease patient considering pregnancy, hormonal contraception or infertility treatment.",
author = "Sammaritano, {Lisa R.} and Bermas, {Bonnie L.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1007/978-1-4939-0673-4",
language = "English (US)",
isbn = "1493906720",
publisher = "Springer New York",

}

TY - BOOK

T1 - Contraception and pregnancy in patients with rheumatic disease

AU - Sammaritano, Lisa R.

AU - Bermas, Bonnie L.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Rheumatic (or systemic autoimmune) diseases disproportionately affect young women: the female-to-male ratio for patients with systemic lupus erythematosus during the reproductive years is approximately 9:1. In the mid-to late-twentieth century, women with rheumatic disease diagnoses were often advised to avoid pregnancy due to fear of disease exacerbation and adverse outcome. In more recent years, many women with rheumatic disease have deferred childbearing until a later age due to active disease or unsafe therapies. However, with advances in rheumatology therapies, obstetric monitoring, and reproductive medicine technologies, increasing numbers of women with rheumatic diseases are pursuing pregnancy. As a result, obstetricians and rheumatologists need to be aware of the current state of knowledge and the recommendations for management of pregnancy in these patients. Contraception and Pregnancy in Patients with Rheumatic Disease explains the basics of contraception, fertility treatment, and pregnancy in rheumatic disease patients and serves as a guide and reference tool for both rheumatologists and OB/GYNs. Most general rheumatologists and OB/GYNs have limited experience in caring for rheumatic disease patients during pregnancy, and many do not have ready access to expert colleagues in this area. This book summarizes the current state of knowledge and presents a general approach for assessment of the rheumatic disease patient considering pregnancy, hormonal contraception or infertility treatment.

AB - Rheumatic (or systemic autoimmune) diseases disproportionately affect young women: the female-to-male ratio for patients with systemic lupus erythematosus during the reproductive years is approximately 9:1. In the mid-to late-twentieth century, women with rheumatic disease diagnoses were often advised to avoid pregnancy due to fear of disease exacerbation and adverse outcome. In more recent years, many women with rheumatic disease have deferred childbearing until a later age due to active disease or unsafe therapies. However, with advances in rheumatology therapies, obstetric monitoring, and reproductive medicine technologies, increasing numbers of women with rheumatic diseases are pursuing pregnancy. As a result, obstetricians and rheumatologists need to be aware of the current state of knowledge and the recommendations for management of pregnancy in these patients. Contraception and Pregnancy in Patients with Rheumatic Disease explains the basics of contraception, fertility treatment, and pregnancy in rheumatic disease patients and serves as a guide and reference tool for both rheumatologists and OB/GYNs. Most general rheumatologists and OB/GYNs have limited experience in caring for rheumatic disease patients during pregnancy, and many do not have ready access to expert colleagues in this area. This book summarizes the current state of knowledge and presents a general approach for assessment of the rheumatic disease patient considering pregnancy, hormonal contraception or infertility treatment.

UR - http://www.scopus.com/inward/record.url?scp=84929922582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929922582&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-0673-4

DO - 10.1007/978-1-4939-0673-4

M3 - Book

AN - SCOPUS:84929922582

SN - 1493906720

SN - 9781493906727

BT - Contraception and pregnancy in patients with rheumatic disease

PB - Springer New York

ER -